Sealmatic's new 15% guidance meets a credibility deficit from the last one
After missing its own FY26 growth and margin targets, management offers fresh targets without acknowledging the old miss.
The numbers
- FY26 revenue grew 2%, falling far short of the 15-20% growth CEO Umar Balwa had guided for in June 2025.
- EBITDA margin compressed 700 bps year-on-year to 17%, missing the 20% target Balwa set in November 2025.
- Net profit fell 35% to ₹10.32 cr in FY26, down from ₹15.91 cr in FY25.
- Sealmatic supplied 686 API seals to Middle East projects with 230 more under execution, a multi-year aftermarket bet now in its early innings.
- At a ₹376 cr market capitalization and 36.5x P/E, the stock prices in a recovery that hasn't arrived.
Management's story
- CEO Umar Balwa guided for 15% revenue growth and 23-24% EBITDA margins for FY27.
- Management framed the FY26 margin drop as a deliberate strategic choice, citing ₹13 crore of spending on exhibitions and below-cost introductory API seal pricing.
- The company positioned its 916-unit installed base of API seals as the foundation for a recurring aftermarket revenue stream over a 35-year equipment life.
- Sealmatic declined to provide specific guidance on the timeline for its third manufacturing unit.
“We are looking at a growth of 15% to 20% every year year-on-year.”
— CEO Umar Balwa, June 2025 call
Where they diverge
The core tension is credibility. Sealmatic is asking investors to trust a 15% growth and margin recovery forecast from a management team that delivered 2% growth against its own 15-20% target just one year ago. The ₹13 crore strategic spend explains part of the margin miss, but not the full 700 bps compression or the revenue shortfall. A 36.5x P/E leaves no room for another miss.
The full read
Sealmatic India enters FY27 with a new set of targets and an old problem: credibility. The company is guiding for 15% revenue growth and 23-24% EBITDA margins after delivering just 2% growth and 17% margins in FY26, missing the CEO's own forecasts from June and November 2025. Management frames the weak year as a strategic investment, spending ₹13 crore on global exhibitions and below-cost API seal pricing to build a base for future aftermarket revenue. That long-term bet may be sound. The short-term numbers are not. Net profit fell 35% to ₹10.32 cr, and the 700 bps margin compression was not fully explained by the disclosed ₹13 crore spend. The stock trades at 36.5x earnings on a ₹376 cr market cap, pricing in the recovery that management now promises. The aftermarket revenue from 916 API seals is years away, with commissioning delays already pushing the payoff into FY28. If FY27 delivers the guided 15% growth, the stock can re-rate. If it doesn't, the trust gap that opened in FY26 will harden into a discount. Management has given investors a new forecast and no reason to believe it.
What we're watching
- Whether FY27 revenue grows 15% as guided, a threshold that would begin to restore management's forecasting credibility.
- The pace of API seal commissioning. Delays have already stretched to seven months, pushing the aftermarket revenue payoff into FY28.
- The trajectory of EBITDA margins as the ₹13 crore exhibition and pricing spend normalizes, testing the 23-24% target.